Medsafe

This report provides information on the number of adverse events following immunisation (AEFI) reports received for COVID-19 vaccines

Fewer than half of pharmacies audited in the last quarter of 2020 are achieving “full compliance”, according to the latest Pharmacy Quality Audits figures, falling from 56 to 45 per cent on the previous quarter

Medsafe is standing by its statement that the anti-COVID nasal spray Enovid cannot be sold in New Zealand, despite claims to the contrary from the Canadian company that makes it

Medsafe has denied claims that a Canadian anti-COVID nasal spray has been approved for sale in New Zealand

Medsafe acknowledges it’s been a tough year for pharmacy but is working with sector groups to improve performance

Communication between people with epilepsy, their doctors and between agencies, around the potential risks of switching brands of anti-epileptic lamotrigine was examined at today’s epilepsy deaths inquest 

Hugh Lopdell from Oak Park Chartered Accountants made a splash on Facebook with his video on the state of play in New Zealand pharmacy after the arrival of large discount pharmacies. Here, you can read the text of his popular video 

The Pfizer-BioNTech vaccine has been provisionally approved by Medsafe, with certain conditions placed on the company

The Medicines Classification Committee is forging ahead with its recommendation to reclassify pholcodine after considering objections, but says reclassification for paracetamol is not required

It’s been a turbulent year for Medsafe, as latest figures show the authority conducted 108 audits on pharmacies across New Zealand before the global pandemic quickly derailed almost all pharmacy audits for months